KEGG   PATHWAY: zca04650
Entry
zca04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Zalophus californianus (California sea lion)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
zca04650  Natural killer cell mediated cytotoxicity
zca04650

Other DBs
GO: 0042267
Organism
Zalophus californianus (California sea lion) [GN:zca]
Gene
113907897  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
113908122  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
113908972  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
113908979  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
113909272  [KO:K01353] [EC:3.4.21.79]
113909494  SHC4; SHC-transforming protein 4 isoform X1 [KO:K17449]
113910204  [KO:K01353] [EC:3.4.21.79]
113911009  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
113911688  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
113912225  [KO:K05414]
113912320  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
113912429  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
113914876  HRAS; GTPase HRas isoform X1 [KO:K02833]
113914974  PAK1; serine/threonine-protein kinase PAK 1 isoform X1 [KO:K04409] [EC:2.7.11.1]
113915274  [KO:K04722]
113916244  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
113916429  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
113916701  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
113916957  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
113917006  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
113917022  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
113917179  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
113917495  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
113917867  SHC2; SHC-transforming protein 2 isoform X1 [KO:K17447]
113918089  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
113918583  IFNGR2; interferon gamma receptor 2 [KO:K05133]
113918669  ITGB2; integrin beta-2 isoform X1 [KO:K06464]
113918898  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
113919467  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
113919987  [KO:K04392]
113921679  PRF1; perforin-1 [KO:K07818]
113921792  KRAS; GTPase KRas isoform X1 [KO:K07827]
113921804  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
113922032  [KO:K06728]
113922097  IFNG; interferon gamma isoform X1 [KO:K04687]
113922131  [KO:K06541]
113922132  [KO:K06541]
113922198  KLRD1; natural killer cells antigen CD94 isoform X1 [KO:K06516]
113922586  [KO:K06541]
113922696  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
113922975  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
113923028  PTPN6; LOW QUALITY PROTEIN: tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
113924138  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
113924414  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
113924509  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
113924761  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
113924764  SH3BP2; LOW QUALITY PROTEIN: SH3 domain-binding protein 2 [KO:K07984]
113924963  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
113926172  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
113927268  [KO:K06742]
113927325  IFNGR1; LOW QUALITY PROTEIN: interferon gamma receptor 1 [KO:K05132]
113927359  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
113927500  [KO:K07986]
113927501  [KO:K07986]
113927740  TNF; tumor necrosis factor [KO:K03156]
113927743  NCR3; natural cytotoxicity triggering receptor 3 isoform X1 [KO:K06743]
113927837  RAET1E; retinoic acid early transcript 1E [KO:K07987]
113927962  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
113928897  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
113928914  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
113929387  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
113930205  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
113931510  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
113931754  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
113931755  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
113931879  NRAS; GTPase NRas [KO:K07828]
113932258  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
113932280  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
113932378  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
113932499  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
113932720  LAT; linker for activation of T-cells family member 1 isoform X2 [KO:K07362]
113932959  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
113933024  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
113933201  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
113933258  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
113933611  CD48; CD48 antigen [KO:K06479]
113933711  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
113933742  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
113934090  [KO:K07293] [EC:3.1.3.48]
113934411  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
113934419  IFNB1; interferon beta [KO:K05415]
113934433  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
113934655  [KO:K05414]
113934667  [KO:K05414]
113934678  [KO:K05414]
113934682  [KO:K05414]
113934908  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
113934985  [KO:K05414]
113935041  SHC3; SHC-transforming protein 3 isoform X1 [KO:K17448]
113935651  [KO:K07992]
113935662  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
113935801  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
113935857  NCR1; natural cytotoxicity triggering receptor 1 [KO:K06741]
113936075  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
113936670  VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730]
113937127  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
113937385  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
113938162  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
113938221  [KO:K07360] [EC:2.7.10.2]
113938304  PLCG1; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
113939477  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
113939579  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
zca04010  MAPK signaling pathway
zca04020  Calcium signaling pathway
zca04060  Cytokine-cytokine receptor interaction
zca04210  Apoptosis
zca04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system